4 Dec 17

Finally, Dr. Vinet's team viewed whether medicines taken during pregnancy potentially played a role in ASD diagnosis in this study. They viewed a smaller group of 1,925 kids, whose mothers had general public drug coverage, and found exposures to medicines during pregnancy were rare. In fact, in the 18 ASD cases seen in offspring of lupus mothers with public drug coverage, none of the young children were exposed to antimalarials, antidepressants, or immunosuppressants during pregnancy. And, only one kid born to a mom with lupus and another born to a mother without the disease were subjected to corticosteroids and anticonvulsants, respectively. The findings from this research suggest that, although the complete risk is relatively small, when compared to children from the overall population, children born to women with lupus have a two-fold increased risk of autism spectrum disorders, says Dr.Researchers report that the new medication, which is definitely administered intravenously, reduced the odds of problems from stenting procedures. Specifically, those that received cangrelor experienced a lower combined incidence of loss of life, myocardial infarction, ischemia-powered revascularization, or stent thrombosis at 48 hours after randomization. ‘We have become excited about the prospect of this new medicine to reduce complications in patients getting coronary stents for a wide variety of indications. Not only is it much quicker to take effect and more potent than currently obtainable treatment options, this intravenous medication is has and reversible an easy offset of actions, which could become an edge if emergency surgery is needed.’ said Deepak L.